Next-Generation Delivery and Diagnostics Symposium Agenda

**All Information is Subject to Change**

Click Here to View Speaker Bios

Wednesday, September 21

9:15 AM - 9:30 AM (EDT)

Welcome & Logistics

Dr. Simon Matoori

Symposia Co-Chair & Moderator 

Assistant Professor, Université de Montréal


9:30 AM - 11:00 AM (EDT)

Session 1: Robotic Devices for Drug Delivery

Over the last two decades, a variety of robotic delivery systems have been developed. Robots at the nano-, micro-, and macroscale sense the environment and trigger the drug release autonomously. Robotic capsules monitor vital signs, and release a drug when a patient’s status deteriorates. Self-administered robotic infusion systems are simplifying drug administration of biologics, improving compliance and enabling home administration. This session covers robotic delivery systems at different length scales, and the potential and challenges of robotics in drug delivery. 

Dr. Beate Bittner 

Symposia Co-Chair & Moderator

Product Optimization Franchise Leader, F. Hoffmann - La Roche


Dan Bacher

Digital Health and Drug Delivery In One Capsule

VP Research & Development, Celero Systems Inc.


Eric Schiller

Innovation opportunities for IV infusion at home



Dr. Chris Franzese

Innovation opportunities for IV infusion at home


Dr. Wei Gao

Ingestible microrobots: From test tubes to live animals


11:00 AM - 11:30 AM (EDT)


11:30 AM - 12:30 PM (EDT)

Keynote Speaker

Dr. Giovanni Traverso

Assistant Professor, Department of Mechanical Engineering, Massachusetts Institute of Technology

Assistant Professor of Medicine (part-time), Division of Gastroenterology, Brigham and Women’s Hospital, Harvard Medical School


12:30 PM - 1:00 PM (EDT)


1:00 PM - 3:30 PM (EDT)

Session 2: Delivery Systems for Diagnostic Use

Academia has recently repurposed a range of established delivery systems (microneedles, liposomes, robotic devices) for diagnostic purposes. Industry is also focusing on diagnostics as they allow for the identification of patients most likely to benefit from treatment and the assessment of treatment response. Indeed, companion diagnostics are key to the success of many new therapies, and increasingly required for FDA approval. In analogy to drug delivery systems, the properties of diagnostic formulations determine their success: the release kinetics of the diagnostic agent, their stability and shelf-life, and manufacturing considerations such as scale-up. The sessions explore the challenging development of diagnostic delivery systems from different angles: the industrial perspective and the perspective of translationally focused academic institutions. 

Dr. Simon Matoori

Symposia Co-Chair & Moderator 

Assistant Professor, Université de Montréal


Dr. Rushdy Ahmad

Wyss Diagnostics Accelerator, Harvard University


Leo Hofmann

TS-01 - An innovative ammonia assay based on transmembrane pH-gradient polymersomes


Dr. Thierry Bettinger

Microbubbles plaform: A modular technology for disruptive approaches in medicine


Dr. Davide Brambila

Naked eye invisible microtattoos for diagnostic and monitoring applications

Université de Montréal

Dr. Matthew Burton

Disrupting Diagnostics

Detact Diagnostics

3:30 PM - 4:00 PM (EDT)

Wrap Up and Closing Words


Thursday - September 22, 2022

9:15 AM - 9:30 AM (EDT)

Welcome and Logistics

Dr. Simon Matoori

Symposia Co-Chair & Moderator 

Assistant Professor, Université de Montréal


9:30 AM - 12:30 PM (EDT)

Session 3: How to Define and Nurture Breakthrough Technologies

What makes a technology a breakthrough technology? And how can a technology be improved? In this session, we are aiming to answer these questions with key stakeholders along the drug development path. An editor will talk about how they pick manuscripts and reviewers; a Venture Capital company will elaborate on how they pick startups and provide ecosystems for these startups to grow; a Medical Doctor will talk about a recent advance in treatment; and a life cycle management expert will provide their insights into breakthrough formulations for approved drugs. These experts will define true breakthroughs from bench to bedside.  

Dr. Beate Bittner 

Symposia Co-Chair & Moderator 

Product Optimization Franchise Leader, F. Hoffmann - La Roche


Dr. Christine Horejs

Publishing breakthrough technologies - an editorial perspective

Editor in Chief, Nature Reviews Bioengineering


Dr. Felix Schumacher

Drug delivery to the brain - a landscape

Program Leader Targeted Therapeutics, Roche


Dr. Josh Horvath

Long-Acting Ocular Drug Delivery: the Port Delivery System for Ranibizumab

Senior Director, Genentech


Dr. Dennis Lee

Novel Drug Delivery Solutions for Challenging Product Concepts in Global Health

Bill and Melinda Gates Foundation

Dr. Manuel Sanchez-Felix

Patient Focused Breakthrough Drug Delivery Technologies


Dr. Athanas Koynov



12:30 PM - 1:00 PM (EDT)


1:00 PM - 3:30 PM (EDT)

Session 4: How Artificial Intelligence is Revolutionizing the Drug Formulation Workflow

Drug formulation science has traditionally relied on iterative optimization of formulations involving laborious in vitro and in vivo studies. Having made breakthrough contributions in medicine and drug discovery, artificial intelligence offers opportunities to reduce experimentation and quality control testing by the use of training sets to predict the properties of new formulations and batches of established formulations. First studies showed how machine learning systems successfully predicted drug release kinetics from polymeric implants and the in vivo biodistribution of nanoparticles. These two sessions will highlight how artificial intelligence is revolutionizing the drug formulation workflow from excipient selection to animal testing. 

Dr. Daniel Reker

Machine Learning to Discover Functional Excipients and Nanoparticles

Assistant Professor, Duke University 


Dr. Christine Allen

Harnessing Automation and Machine Learning to Accelerate Drug Formulation Development

Professor, University of Toronto


Dr. Maksim Khotimchenko

A novel AI/ML-driven In silico simulation of the opioid drug transdermal absorption in normal skin and cutaneous lesions

Principal DMPK Scientist, VeriSIM Life Inc.


Dr. Natalie Boehnke

Nanoparticle delivery through the lens of omics

Assistant Professor, University of Minnesota


Dr. Adam Gormley

Machine Learning-Guided Robotics for the Data-Driven Design of Nanomaterials

Rutgers University

3:30 PM - 4:00 PM (EDT)

Wrap Up and Closing Words